Childhood vaccinations: Hidden impact of COVID-19 on children in Singapore

•MMR vaccine uptake rates have dropped between 25.64%−73.55% during COVID-19.•A measles epidemic is a possibility due to reduction in community herd immunity.•Urgent public health efforts are needed to maintain efficacious vaccine coverage. Although the direct health impact of Coronavirus disease (C...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2021-01, Vol.39 (5), p.780-785
Hauptverfasser: Zhong, Youjia, Clapham, Hannah Eleanor, Aishworiya, Ramkumar, Chua, Ying Xian, Mathews, Jancy, Ong, Mabel, Wang, Jingji, Murugasu, Belinda, Chiang, Wen Chin, Lee, Bee Wah, Chin, Hui-Lin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•MMR vaccine uptake rates have dropped between 25.64%−73.55% during COVID-19.•A measles epidemic is a possibility due to reduction in community herd immunity.•Urgent public health efforts are needed to maintain efficacious vaccine coverage. Although the direct health impact of Coronavirus disease (COVID-19) pandemic on child health is low, there are indirect impacts across many aspects. We compare childhood vaccine uptake in three types of healthcare facilities in Singapore - public primary care clinics, a hospital paediatric unit, and private paediatrician clinics - from January to April 2020, to baseline, and calculate the impact on herd immunity for measles. We find a 25.6% to 73.6% drop in Measles-Mumps-Rubella (MMR) uptake rates, 0.4 – 10.3% drop for Diphtheria-Tetanus-Pertussis-inactivated Polio-Haemophilus influenza (5-in-1), and 8.0–67.8% drop for Pneumococcal conjugate vaccine (PCV) across all 3 sites. Consequent herd immunity reduces to 74–84% among 12-month- to 2-year-olds, well below the 95% coverage that is protective for measles. This puts the whole community at risk for a measles epidemic. Public health efforts are urgently needed to maintain efficacious coverage for routine childhood vaccines during the COVID-19 pandemic.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2020.12.054